Actoplus Met is a combination medicine that is licensed to treat type 2 diabetes in adults. This eMedTV article describes the drug in detail and explains how it works, lists its possible side effects, and offers general dosing information.
Common Actoplus Met side effects may include swelling or fluid retention, weight gain, and nausea. This eMedTV page lists additional side effects, including other common problems and rare but serious side effects that may require medical attention.
This eMedTV page discusses research findings on Actoplus Met and weight gain (about 7 percent of people taking it experience weight gain). It also explains the dangers of rapid weight gain and offers tips for helping with gradual weight gain.
Actoplus Met may cause blood sugar to become too low or too high. This eMedTV segment discusses Actoplus Met and blood sugar in more detail, including a list of possible low and high blood sugar symptoms, such as blurred vision or extreme hunger.
Actoplus Met is used to lower blood sugar in adults with type 2 diabetes. As this eMedTV article explains, it can decrease the amount of sugar absorbed into the body and improve insulin sensitivity. This page also covers off-label Actoplus Met uses.
When switching from pioglitazone to Actoplus Met, the dosage usually starts at 15 mg/500 mg or 15 mg/850 mg. This eMedTV page also offers dosage guidelines for those replacing metformin with Actoplus Met and provides tips for taking the medicine.
Atazanavir, diuretics, and niacin may potentially cause Actoplus Met drug interactions. This eMedTV page lists other drugs that may lead to interactions with Actoplus Met and describes the possible side effects that may occur with each interaction.
This eMedTV article provides several Actoplus Met warnings and precautions, offers information on who should not take the drug, and lists possible side effects to look out for. For example, people with severe kidney disease should not take the drug.
Actoplus Met is not licensed to treat type 1 diabetes. However, this eMedTV article explores a possible link between Actoplus Met and type 1 diabetes -- for example, in some cases, the drug may be combined with insulin to treat this type of diabetes.
Due to the possible effects of Actoplus Met on fetuses, the drug is not recommended during pregnancy. This eMedTV article discusses Actoplus Met and pregnancy in more detail, including information on when the drug may be prescribed during pregnancy.
An Actoplus Met overdose may result in low blood sugar or lactic acidosis. This page of the eMedTV library lists the possible symptoms of each condition and discusses the treatment options that are available, such as IV fluids or supportive care.
An approved generic Actoplus Met will not be available until 2011, at the earliest. This eMedTV resource explains why this is the case, lists factors that may extend this to a later date, and discusses insurance coverage for the medication.
Actoplus Met alternatives may include other diabetes medicines or lifestyle changes. This eMedTV Web page describes possible lifestyle changes and lists both oral and injectable diabetes drugs that can be used in place of Actoplus Met.
| Referring Pages | Articles |
